Epicardial lead design

US2024050737A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2024050737-A1
Application numberUS-202318234269-A
CountryUS
Kind codeA1
Filing dateAug 15, 2023
Priority dateMay 8, 2013
Publication dateFeb 15, 2024
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention provides an advancement in the art of cardiac pacemakers. The invention provides a novel and unobvious pacemaker system that comprises at least one pacemaker and that is, to a large extent, self-controlled, allows for long-term implantation in a patient, and minimizes current inconveniences and problems associated with battery life. The invention further includes a mechanism in which at least two pacemakers are implanted in a patient, and in which the pacemakers communicate with each other at the time of a given pacing or respiratory event, without any required external input, and adjust pacing parameters to respond to the patient's need for blood flow. The invention further provides a novel design for a pacemaker in which the pacemaker electrode is connected to the pacemaker body by a lead that is configured to allow the pacemaker to lie parallel to the epicardial surface and to reduce stress on the pacemaker and heart tissue.

First claim

Opening claim text (preview).

1 . A minimally-invasive, epicardial pacemaker unit comprising: an electrode for delivering an electrical pulse to myocardial tissue of a heart in need thereof; a cardiac pacemaker suitable for delivering electrical pacing to a heart in need thereof; and a hinge physically connecting the electrode to the pacemaker, wherein the hinge allows the electrode and pacemaker to be angularly aligned substantially along a same path prior to deployment into cardiac tissue, but then allows the two to pivot with respect to each other such that the pacemaker portion can lie substantially parallel to the epicardium/myocardium/pericardial sac, and between the epicardium and pericardial sac, while the electrode remains substantially perpendicular to the epicardium/myocardium. 2 . The pacemaker unit of claim 1 , wherein the hinge comprises a lead that includes a coiled bend that allows the pacemaker portion to lie substantially parallel to the epicardium/myocardium/pericardial sac, and between the epicardium and pericardial sac, while the electrode remains substantially perpendicular to the epicardium/myocardium. 3 . The pacemaker unit of claim 1 , wherein the hinge comprises nitinol. 4 . The pacemaker unit of claim 1 , wherein the hinge comprises a hollow structural element comprising an element wall having openings in the element wall. 5 . The pacemaker unit of claim 4 , wherein the hollow structural element is in the form of a cylinder. 6 . The pacemaker unit of claim 1 , wherein the hinge comprises one or more hollow structures having walls with openings. 7 . The pacemaker unit of claims 1 , wherein the hinge comprises one or more bends prior to or after deployment into the cardiac tissue. 8 . The pacemaker unit of claim 7 , wherein there is a single bend in the lead, which is approximately 90°. 9 . A minimally-invasive, modular epicardial pacemaker system, said system comprising: at least two pacemakers, at least one of which being embedded in, and electrically connected to, myocardial tissue of a heart by way of transit through epicardial tissue, wherein at least one of said pacemakers is implanted between atrial epicardial tissue and the pericardial sac, and is optionally embedded in atrial myocardial tissue of the heart by way of an electrically conductive electrode, and wherein at least one of said pacemakers is embedded in ventricular tissue of the heart, and wherein one or more of the pacemakers communicates electrically, electronically, or both with one or more of the other pacemakers of the system to convey information about cardiac rhythm, pacing events, or both so as to coordinately pace the atrium and ventricle of the heart, wherein the information comprises data indicative of the respiration rate of the patient. 10 . The system of claim 9 , wherein the information comprises data that match demand and pacing for the at least two pacemakers. 11 . The system of claim 10 , wherein the data is derived from measurements of changes in electrical currents between the various pacemakers, wherein changes indicate differences in the density and/or volume of the chest cavity of the patient in which the system is deployed. 12 . The system of claim 10 , wherein the system comprises one or more pacemaker units having the following features: an electrode for delivering an electrical pulse to myocardial tissue of a heart in need thereof; a cardiac pacemaker suitable for delivering electrical pacing to a heart in need thereof; and a hinge physically connecting the electrode to the pacemaker, wherein the hinge allows the electrode and pacemaker to be angularly aligned substantially along a same path prior to deployment into cardiac tissue, but then allows the two to pivot with respect to each other such that the pacemaker portion can lie substantially parallel to the epicardium/myocardium/pericardial sac, and between the epicardium and pericardial sac, while the electrode remains substantially perpendicular to the epicardium/myocardium. 13 . (canceled) 14 . A process of implanting a pacemaker unit into a patient, said process comprising: using a hypodermic needle to introduce a guide wire into the pericardial space of the heart from a subxyphoid approach; withdrawing the hypodermic needle over the wire; replacing the hypodermic needle with a dilator and a sleeve, which are advanced through the skin and intervening tissues until their distal ends are also in the pericardial space; removing the dilator and guide wire from the sleeve; replacing the dilator and guide wire with an insertion sheath, which includes a module affixed within its distal portion; advancing the sheath through the lumen of the sleeve until the module is located adjacent to the right or left atrium or ventrical and within the pericardial sac; and optionally implanting an electrode of the pacemaker into the myocardium of the patient's heart by way of the epicardium, wherein the pacemaker unit comprises: an electrode for delivering an electrical pulse to myocardial tissue of a heart in need thereof; a cardiac pacemaker suitable for delivering electrical pacing to a heart in need thereof; and a hinge physically connecting the electrode to the pacemaker, wherein the hinge allows the electrode and pacemaker to be angularly aligned substantially along a same path prior to deployment into cardiac tissue, but then allows the two to pivot with respect to each other such that the pacemaker portion can lie substantially parallel to the epicardium/myocardium/pericardial sac, and between the epicardium and pericardial sac, while the electrode remains substantially perpendicular to the epicardium/myocardium. 15 . The process of claim 14 , wherein the hinge comprises a lead that includes a bend that allows the pacemaker portion to lie substantially parallel to the epicardium/myocardium/pericardial sac, and between the epicardium and pericardial sac, while the electrode remains substantially perpendicular to the epicardium/myocardium. 16 . The process of claim 14 , wherein the bend in the lead is approximately 90°.

Assignees

Inventors

Classifications

  • A61N1/0587Primary

    Epicardial electrode systems; Endocardial electrodes piercing the pericardium · CPC title

  • Casings with electrodes thereon, e.g. leadless stimulators · CPC title

  • Anchoring means · CPC title

  • Heart stimulators (heart defibrillators A61N1/39) · CPC title

  • Microstimulators, e.g. implantable through a cannula · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2024050737A1 cover?
The present invention provides an advancement in the art of cardiac pacemakers. The invention provides a novel and unobvious pacemaker system that comprises at least one pacemaker and that is, to a large extent, self-controlled, allows for long-term implantation in a patient, and minimizes current inconveniences and problems associated with battery life. The invention further includes a mechani…
Who is the assignee on this patent?
Los Angeles Childrens Hospital, Univ Southern California
What technology area does this patent fall under?
Primary CPC classification A61N1/0587. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Thu Feb 15 2024 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).